NNHF Unveiled at ASH2025: Expanding Beyond Haemophilia Care to Include SCD and Thalassemia
Amos Gitonga M, Associate Programme Manager-Southern Africa at Novo Nordisk Haemophilia and Haemoglobinopathies Foundation, shared a post on LinkedIn:
“While some of our Novo Nordisk Haemophilia and Haemoglobinopathies Foundation (NNHF) colleagues unveiled at ASH2025 in Orlando, we celebrated an inspiring Africa Unveil in Nairobi, Kenya NNHF Africa Unveil.

Together with partners from across Africa, we marked a bold new chapter: expanding beyond haemophilia care to include sickle cell disease (SCD) and thalassemia.
After two decades of impact, this is a new horizon and a momentum we are excited to carry forward. I look forward to working with incredible partners in Africa to strengthen care where it is most needed.
Our shared goal: to build an integrated model of care for haemophilia and SCD, while also advancing tailored approaches for each condition as needed. By leveraging shared resources, we aim to strengthen service delivery and improve access, and outcomes for people living with these conditions.”
Read more about ASH2025 on Hemostasis Today.
-
Jan 13, 2026, 13:03Claudio Laudani on Dual Versus Single Antiplatelet Therapy
-
Jan 13, 2026, 12:46Stephanie Carlin and Colleagues on Clinical Outcomes of DOAC-Anticonvulsant Coprescription
-
Jan 13, 2026, 10:53Lena Volland on Ming Y Lim’s Example of Designing Care Models for WGBD Community With Intention
-
Jan 13, 2026, 05:05Pablo Corral Shares Key Takeaways on Reducing LDL-Cholesterol to Very Low Levels
-
Jan 13, 2026, 04:49Martin Haluzík Shares A Study on GLP1-1RAs Use in Peripheral Artery Disease and DM
-
Jan 13, 2026, 04:37Shreya Agarwal and Bryce A Kerlin on The Impact of Advanced Hemostasis and Thrombosis Fellowship Trainings
-
Jan 13, 2026, 03:53Christian Schulze Shares New Data from DANGERSHOCK
-
Jan 13, 2026, 03:39Samwel Mikaye Breaks Down Peripheral Blood Smear
-
Jan 12, 2026, 20:15Mazou Ngou Temgoua on SCAF: Subclinical Atrial Fibrillation on Treatment with Apixaban or Aspirin
